Lupus Capital PLC
10 January 2007
LUPUS CAPITAL PLC
PRE - CLOSE TRADING STATEMENT 10 January 2007
Lupus is pleased to report that it anticipates a record set of results for the
year ended December 31, 2006 together with the successful integration of
Schlegel Building Products, which was acquired on April 4, 2006. As a
consequence, profits, earnings, cash generation and dividends are all likely to
exceed analysts' expectations.
Gall Thomson Environmental, which operates primarily in the oil and gas sector,
has had its best ever year, surpassing 2005 in sales, profits, cash generation
and also return on capital employed. The year end order book, comprising both
marine and industrial breakaway couplings, is at an all time high which bodes
well for 2007.
The nine month contribution from the acquisition of Schlegel has been very
positive. The management has responded well both to the change of ownership and
new direction and has improved on key performance indicators over 2005. New
customers have been won, productivity has improved, prices have been raised to
compensate for raw material inputs, sales have been refocused into higher margin
customers, financial controls have been tightened and action from exhaustive
analysis has yielded higher gross margins. The global market for housing has
been generally satisfactory with the long term worldwide trend being upwards.
As an international business with activities across three continents we have a
limited exposure to both Dollar currency and the current US new build housing
market difficulties where we have taken action to mitigate any effects. 2006
has seen many exciting changes to Schlegel, which has produced increased
profitability over the previous year and which we hope to build on.
On the corporate front:
A comprehensive tax review is being undertaken with the expected outcome that
our worldwide group cash tax rate should decline from an anticipated 38 per cent
band previously planned. We continue to seek the development of Lupus through
both organic growth and selective acquisitions.
The excellent cash generation from both our businesses has enabled Lupus to
reduce the net debt taken on to buy Schlegel at a speed quicker than originally
envisaged. It will also provide funds to increase our dividend to shareholders
for the 2006 year at a higher rate than forecast at the time of the Schlegel
acquisition. This is likely to be a recommendation of at least a 20 per cent
increase over the .410p net dividend for the 2005 year.
Record order books at Gall Thomson together with a 12 month contribution from
the global activities of Schlegel, rather than nine months in 2006, enable us to
enter 2007 with optimism.
We look forward to another year of growth and development of Lupus Capital Plc.
Enquiries to:
Greg Hutchings 020 7976 8000
Alan Frame 020 7405 7777
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.